News & events

ACE inhibitors and ARBs not associated with severity of Coronavirus

Researchers have found ACE inhibitors (a type of blood pressure medicine commonly used in patients with high blood pressure or diabetes) and ARBs (used to treat heart failure and high blood pressure) did not increase the severity of COVID-19 disease in patients in two hospitals.

By NIHR Maudsley BRC at 7 Jul 2020

Trial testing a unique formulation of ibuprofen to treat COVID-19 launches

A trial of a unique formulation of ibuprofen treatment for treating severe acute respiratory distress syndrome (ARDS), a complication of COVID-19, has launched in south London.

By NIHR Maudsley BRC at 1 Jun 2020

Mental health and brain research must be a higher priority in global response to tackle COVID-19 pandemic

There is an urgent need to tackle the harmful impacts of the COVID-19 pandemic on mental health and potentially the brain, and for research on these areas to be central to the global response to the pandemic, according to a new position paper.

By NIHR Maudsley BRC at 15 Apr 2020

Researchers appeal to public for help to assess mental health impact of the COVID-19 pandemic

Scientists are appealing to the public for help to assess the mental health impact of the COVID-19 pandemic, with the aim to inform and improve future policies concerning pandemics.

By NIHR Maudsley BRC at 8 Apr 2020

Largest ever study of eating disorders launches in England

A National Institute for Health Research (NIHR) funded study launched today (Wednesday 26 February) is aiming to recruit at least 10,000 people in England who have experienced an eating disorder at some point in their life to a pioneering new study that aims to unlock the secrets of eating disorders.

By NIHR Maudsley BRC at 26 Feb 2020